Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin for Limb Pain in CRPS
NCT03616262Phase 1Unknown
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jul 2016
- Primary completion
- Dec 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of botulinum toxin type A in complex regional pain syndrome (CRPS) (2 arms), sponsored by United States Department of Veterans Affairs. Primary endpoint: Reduction in Visual Analog Scale Score at 7 months. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
complex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on NCT03616262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03616262.